Hidrasec

Hidrasec is an oral medication that contains the active ingredient racecadotril. It is marketed in the European Union as an enkephalinase inhibitor and is classified as an antidiarrheal drug. The product is intended for use in patients experiencing acute diarrhea, offering a pharmacological approach that targets intestinal fluid secretion without affecting systemic opioid pathways.

Hidrasec is indicated for the symptomatic treatment of acute diarrhea in adults and children. It is used as an adjunct to rehydration therapy to reduce stool frequency and volume. The medication may be considered when rapid control of diarrheal output is desired. It is not intended for chronic diarrheal conditions or for use in patients with known hypersensitivity to racecadotril.

- Management of acute infectious diarrhea - Adjunct to oral rehydration solutions in mild to moderate cases - Short‑term relief of watery stools in travelers' diarrhea - Supportive therapy for diarrhea associated with gastroenteritis - Use in pediatric patients when dosage is appropriate

Adverse reactions to Hidrasec are generally mild, but patients should be aware of possible side effects.

Common: - Nausea - Headache - Dizziness - Abdominal discomfort - Flatulence

Serious: - Allergic skin reactions (rash, urticaria) - Severe hypersensitivity (angioedema, anaphylaxis) - Persistent vomiting that interferes with oral intake

Before starting Hidrasec, consider the following safety points. The medication should be used with caution in patients with known hypersensitivity to racecadotril or any excipients. Its safety in pregnancy and lactation has not been established, so a risk‑benefit assessment is required. Use is not recommended for chronic diarrheal disorders without medical supervision. Monitor for signs of dehydration, especially in children and the elderly. Discontinue if severe allergic reactions occur. Consult a healthcare professional if diarrhea persists beyond 48‑72 hours.

Hidrasec may interact with other medications, influencing its efficacy or safety.

Avoid: - Concomitant use with other antidiarrheal agents (e.g., loperamide) without medical advice - Strong CYP enzyme inhibitors that could alter racecadotril metabolism

Use with caution: - Anticholinergic drugs that may affect gastrointestinal motility - Medications that prolong QT interval - Oral rehydration solutions containing high sodium concentrations - Drugs that cause electrolyte imbalance (e.g., diuretics)